Alpharx Inc Sample Contracts

AutoNDA by SimpleDocs
AMENDMENT AGREEMENT
Amendment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations
EXHIBIT 4(ii) AMENDMENT TO THE SUBSCRIPTION AGREEMENT
Subscription Agreement • October 5th, 2004 • Alpharx Inc • Pharmaceutical preparations

The undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and one warrant for one additional share of AlphaRx's common stock, for up to $5,000,000 (the "Agreement") for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, does hereby agree that the deadline for the final closing on page 3 of the Agreement is hereby amended from August 15, 2004 to September 30, 2004.

JOINT VENTURE AGREEMENT ______________ among BASIN INDUSTRIAL LIMITED and ALPHARX INTERNATIONAL HOLDINGS LIMITED and ALPHA AP INC.
Joint Venture Agreement • June 6th, 2005 • Alpharx Inc • Pharmaceutical preparations • New York

This Joint Venture Agreement ("Agreement") is entered into as of this 22nd day of April, 2005 between Basin Industrial Limited, a British Virgin Islands corporation located at 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong ("Basin"), AlphaRx International Holdings Limited, a British Virgin Islands corporation located at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay Hong Kong ("AIH"), and Alpha AP Inc., a British Virgin Islands corporation located at c/o Advance Pharmaceutical Co., Ltd., 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong ("Alpha").

AGREEMENT
Agreement • August 31st, 2012 • Alpharx Inc • Pharmaceutical preparations • Delaware

This AGREEMENT (this “Agreement”), dated as of August 29, 2012, is by and among AlphaRx, Inc., a Delaware corporation (the “Parent”), UMeLook Holdings Limited, a corporation formed pursuant to the laws of the British Virgin Islands (the “Company”), UMeLook Limited, a corporation formed pursuant to the laws of Hong Kong which is the wholly owned subsidiary of the Company (“UMeLook Limited”) and the shareholders of the Company (each a “Shareholder” and collectively the “Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”

SECURITY AGREEMENT
Security Agreement • August 22nd, 2011 • Alpharx Inc • Pharmaceutical preparations • Delaware

This Security Agreement (“Agreement”) is made as of August 22, 2011 by and among AlphaRx, Inc., a Delaware corporation (the “Debtor”), and the parties listed on Schedule A under heading Secured Parties (each a “Secured Party”, and collectively the “Secured Parties”).

MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 1st day of September, 2003,
Manufacturing and Distribution License Agreement • July 8th, 2005 • Alpharx Inc • Pharmaceutical preparations

ALPHARX INC., a corporation incorporated under the laws of the State of Delaware, United States of America, and having its principal place of business at 10-75 East Beaver Creek, Richmond Hill, Ontario, Canada L4B 1B8

MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 22nd day of April, 2005,
Manufacturing and Distribution License Agreement • June 6th, 2005 • Alpharx Inc • Pharmaceutical preparations • New York

AlphaRx International Holdings Limited, a corporation incorporated under the laws of the British Virgin Islands, and having its principal place of business at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay Hong Kong.

FIRST AMENDMENT TO "MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT"
Manufacturing and Distribution License Agreement • June 29th, 2005 • Alpharx Inc • Pharmaceutical preparations

This First Amendment is dated 22nd June 2005, and is made between AlphaRx International Holdings Limited ("AIH"), a corporation incorporated under the laws of the British Virgin Islands, and having its principal place of business at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay, Hong Kong and Alpha AP Inc. ("AAP"), a corporation incorporated under the laws of the British Virgin Islands, and having its principal office c/o Advance Pharmaceutical Co., Ltd., 2/F, 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong.

Time is Money Join Law Insider Premium to draft better contracts faster.